Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Condition: Atrial Fibrillation
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 320 results found since Jan 2013.
Increased Serum Alkaline Phosphatase as a Predictor of Symptomatic Hemorrhagic Transformation in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Elevated alkaline phosphatase (ALP) is considered as a marker of liver function in clinical practice. Furthermore, it has been identified that liver function can contribute to hemorrhagic transformation (HT). However, whether ALP levels play a role in HT after stroke remains an open question, especially in cardioembolic stroke patients.
Source: Journal of Stroke and Cerebrovascular Diseases - July 13, 2016 Category: Neurology Authors: Junfeng Liu, Deren Wang, Jie Li, Yao Xiong, Bian Liu, Chenchen Wei, Simiao Wu, Jing Lin, Ming Liu Source Type: research
Visual Aid Tool to Improve Decision Making in Anticoagulation for Stroke Prevention
The management of stroke prevention among patients with atrial fibrillation (AF) has changed in the last few years. Despite the benefits of new oral anticoagulants (NOACs), decisions about the optimal agent remain a challenge. We provide a visual aid tool to guide clinicians and patients in the decision process of selecting oral anticoagulants for stroke prevention.
Source: Journal of Stroke and Cerebrovascular Diseases - June 14, 2016 Category: Neurology Authors: Gustavo Saposnik, Raed A. Joundi Source Type: research
Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack
This study aimed to explore the detection rate of atrial fibrillation in stroke and transient ischemic attack patients with intermittent handheld ECG in the clinical setting of Halland Hospital Halmstad.
Source: Journal of Stroke and Cerebrovascular Diseases - July 31, 2016 Category: Neurology Authors: Ann-Sofie Olsson, Johan Engdahl Source Type: research
Safely Addressing Patients with Atrial Fibrillation to Early Anticoagulation after Acute Stroke
It has been widely reported that anticoagulants (ACs) are underused for primary and secondary prevention of ischemic stroke in patients with atrial fibrillation (AFib). Furthermore, precise evidence-based guidelines about the best timing for AC initiation after acute stroke are currently lacking.
Source: Journal of Stroke and Cerebrovascular Diseases - September 6, 2016 Category: Neurology Authors: Isabella Canavero, Anna Cavallini, Lucia Sacchi, Silvana Quaglini, Natale Arn ò, Patrizia Perrone, Maria Luisa DeLodovici, Simona Marcheselli, Giuseppe Micieli Source Type: research
Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China
Anticoagulation therapy has been recommended by major guidelines to reduce the risk of recurrent stroke in patients with atrial fibrillation-associated ischemic stroke (AFAIS). However, in real-world clinical practice, oral anticoagulants with either vitamin K antagonists or nonvitamin K antagonists are often underused for these patients. Here, we sought to investigate the current status of oral anticoagulant use in patients with AFAIS in northwestern China.
Source: Journal of Stroke and Cerebrovascular Diseases - September 15, 2016 Category: Neurology Authors: Jing Zhang, Xi-ai Yang, Yi Zhang, Jing-ya Wei, Feng Yang, Hua Gao, Wen-wen Jiao, Xiao-long Sun, Qiong Gao, Wen Jiang Source Type: research
Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source
Biomarkers of atrial dysfunction or “cardiopathy” are associated with embolic stroke risk. However, it is unclear if this risk is mediated by undiagnosed paroxysmal atrial fibrillation or flutter (AF). We aim to determine whether atrial cardiopathy biomarkers predict AF on continuous heart-rhythm monitoring after embolic stroke of undetermined source (ESUS).
Source: Journal of Stroke and Cerebrovascular Diseases - February 21, 2017 Category: Neurology Authors: Denise Sebasigari, Alexander Merkler, Yang Guo, Gino Gialdini, Benjamin Kummer, Morgan Hemendinger, Christopher Song, Antony Chu, Shawna Cutting, Brian Silver, Mitchell S.V. Elkind, Hooman Kamel, Karen L. Furie, Shadi Yaghi Source Type: research
The Value of the Score for the Targeting of Atrial Fibrillation (STAF) Screening in Acute Stroke Patients
In this study, we aim to evaluate the usefulness of the STAF score for AF screening in acute stroke patients.
Source: Journal of Stroke and Cerebrovascular Diseases - February 23, 2017 Category: Neurology Authors: Xiao-Yan Liu, Yong-Xin Li, Yao-Gao Fu, Ye-Yan Cai, Yu-Sheng Zhang, Jiang-Yong Min, An-Ding Xu Source Type: research
Atrial fibrillation modifies the effect of chronic kidney disease on outcome of stroke patients potentially eligible for intravenous thrombolysis
【Background】Atrial fibrillation (Af) increases risk of stroke and is a common comorbidity in patients with chronic kidney disease (CKD). However, the interaction between Af and CKD on stroke outcome has not been determined.
Source: Journal of Stroke and Cerebrovascular Diseases - March 18, 2017 Category: Neurology Authors: Cheng-Yang Hsieh, Huey-Juan Lin, Sheng-Feng Sung, Chih-Hung Chen Source Type: research
Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study
This study explored risk prediction models for ischemic stroke and transient ischemic attack (TIA) in patients without AF.
Source: Journal of Stroke and Cerebrovascular Diseases - April 6, 2017 Category: Neurology Authors: Zhong Yuan, Erica A. Voss, Frank J. DeFalco, Guohua Pan, Patrick B. Ryan, Daniel Yannicelli, Christopher Nessel Source Type: research
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator
Dabigatran is a direct thrombin inhibitor used to reduce the risk of stroke in patients with nonvalvular atrial fibrillation. For patients who present with an acute stroke despite dabigatran therapy, clinical data on the use of intravenous tissue plasminogen activator (IV-tPA) is limited. There is an anticipated increased risk of symptomatic intracranial hemorrhage (sICH) when using IV-tPA in patients on dabigatran therapy. In 2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran.
Source: Journal of Stroke and Cerebrovascular Diseases - April 14, 2017 Category: Neurology Authors: David Bissig, Rashmi Manjunath, Brittany R. Traylor, David P. Richman, Kwan L. Ng Tags: Case Studies Source Type: research
Association between Fibrinogen and Leukoaraiosis in Patients with Ischemic Stroke and Atrial Fibrillation
Leukoaraiosis (LA), a surrogate of cerebral small-vessel diseases (CSVD), has been increasingly recognized because of its high prevalence and strong prognostic value in stroke. But the mechanism of LA is incompletely clarified. Fibrinogen is a crucial role in coagulation cascade and inflammation. There are inconsistent reports on the association of fibrinogen with LA in the general population. We aimed to investigate the association between fibrinogen and LA in patients with stroke and atrial fibrillation (AF), which was not ever reported before.
Source: Journal of Stroke and Cerebrovascular Diseases - August 16, 2017 Category: Neurology Authors: Chen-Chen Wei, Shu-Ting Zhang, Jun-Feng Liu, Jing Lin, Ting-Ting Yang, Shi-Hong Zhang, Ming Liu Source Type: research
Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation
Despite anticoagulation therapy, ischemic stroke risk in atrial fibrillation (AF) remains substantial. We hypothesize that left atrial enlargement (LAE) is more prevalent in AF patients admitted with ischemic stroke who are therapeutic, as opposed to nontherapeutic, on anticoagulation.
Source: Journal of Stroke and Cerebrovascular Diseases - September 13, 2017 Category: Neurology Authors: Katarina Dakay, Andrew D. Chang, Morgan Hemendinger, Shawna Cutting, Ryan A. McTaggart, Mahesh V. Jayaraman, Antony Chu, Nikhil Panda, Christopher Song, Alexander Merkler, Gino Gialdini, Benjamin Kummer, Michael P. Lerario, Hooman Kamel, Mitchell S.V. Elk Source Type: research
Pathophysiology and Risk of Atrial Fibrillation Detected after Ischemic Stroke (PARADISE): A Translational, Integrated, and Transdisciplinary Approach
It has been hypothesized that ischemic stroke can cause atrial fibrillation. By elucidating the mechanisms of neurogenically mediated paroxysmal atrial fibrillation, novel therapeutic strategies could be developed to prevent atrial fibrillation occurrence and perpetuation after stroke. This could result in fewer recurrent strokes and deaths, a reduction or delay in dementia onset, and in the lessening of the functional, structural, and metabolic consequences of atrial fibrillation on the heart.
Source: Journal of Stroke and Cerebrovascular Diseases - November 13, 2017 Category: Neurology Authors: Maryse Paquet, Joshua O. Cerasuolo, Victoria Thorburn, Sebastian Fridman, Rasha Alsubaie, Renato D. Lopes, Lauren E. Cipriano, Paula Salamone, C.W. James Melling, Ali R. Khan, Lucas Sede ño, Jiming Fang, Maria Drangova, Manuel Montero-Odasso, Jennifer Ma Source Type: research
The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation
The severity and the functional outcome of patients with stroke occurring during off-label underdosing of direct-acting oral anticoagulants (DOACs) remain uncertain.
Source: Journal of Stroke and Cerebrovascular Diseases - February 2, 2018 Category: Neurology Authors: Yuji Kato, Takeshi Hayashi, Norio Tanahashi, Masaki Takao Source Type: research
